Liver News and Research

RSS

UT Southwestern performs first regional whole-liver chemotherapy for rare eye cancer

A team at UT Southwestern Medical Center this week became the first in Texas and neighboring states to successfully perform a novel procedure to deliver whole-liver chemotherapy to treat metastatic uveal melanoma, a rare and deadly eye cancer.

21 Jan 2026

GOP promotes MAHA agenda in bid to avert midterm losses. Dems point to contradictions.

When a "Make America Healthy Again" summit was held at the posh Waldorf Astoria in Washington, the line of attendees stretched down the block.

20 Jan 2026

Blood metabolites reveal who will develop type 2 diabetes years before diagnosis

This large prospective study integrated blood metabolomics, genetics, and lifestyle data to identify hundreds of metabolites associated with long-term risk of type 2 diabetes in initially healthy adults. A validated 44-metabolite signature improved risk prediction beyond conventional factors, offering insights into biological pathways and opportunities for earlier, more precise prevention.

18 Jan 2026

Researchers discover how Mycoplasma pneumoniae acquires cholesterol from human hosts

A multidisciplinary team has uncovered a key mechanism that allows the human bacterium Mycoplasma pneumoniae-responsible for atypical pneumonia and other respiratory infections-to obtain cholesterol and other essential lipids directly from the human body.

16 Jan 2026

Father's early behavior linked to child's heart and metabolic health years later

How a new father behaves toward his baby can change family dynamics in a way that affects the child's heart and metabolic health years later, according to a new study by researchers in the Penn State College of Health and Human Development.

16 Jan 2026

New insights into long-term liver injury after Kasai portoenterostomy for biliary atresia

BA is characterized by early destruction of the bile ducts, leading to cholestasis, inflammation, and rapid fibrosis shortly after birth.

16 Jan 2026

Cancer mortality drops 34% as treatments and early detection improve

The 2026 cancer statistics reveal improved survival rates but highlight persistent inequities in cancer incidence and mortality across different populations.

16 Jan 2026

New oral drug safely lowers triglycerides and other blood lipids in Phase 1 trial

In a Phase 1 clinical study, researchers led by EPFL and their partners report that a new liver- and gut-targeted oral drug can safely lower triglycerides and other blood lipids.

16 Jan 2026

UC San Diego project aims to bioprint patient-specific transplantable human livers

Liver failure is one of the most serious and deadly medical conditions, claiming thousands of lives each year as patients in the United States wait for a donor organ.

14 Jan 2026

Gut bacteria compound during pregnancy protects offspring from fatty liver disease

Children born to mothers who consume a high-fat, high-sugar diet during pregnancy and breastfeeding face a higher risk of developing fatty liver disease later in life.

14 Jan 2026

CRISPR-Cas3: A safer gene-editing tool shows promise for transthyretin amyloidosis treatment

Genetic disorders occur due to alterations in the primary genetic material, deoxyribonucleic acid (DNA), of an organism. Transthyretin amyloidosis (ATTR) is a progressive disorder involving amyloid deposits of misfolded transthyretin (TTR) proteins.

14 Jan 2026

PFAS exposure linked to gestational diabetes and insulin problems

Exposure to per- and polyfluoroalkyl substances (PFAS), a class of highly persistent environmental chemicals commonly referred to as "forever chemicals," is associated with a higher risk of gestational diabetes mellitus and altered markers of insulin resistance and insulin secretion, according to a new systematic review and meta-analysis led by researchers at the Icahn School of Medicine at Mount Sinai.

14 Jan 2026

Preclinical study reveals potential new treatment for severe liver fibrosis

Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita Therapeutics that has the potential to prevent and reverse liver fibrosis - a dangerous, disease-induced build-up of scar tissue in the liver that often leads to cancer.

13 Jan 2026

Blocking liver enzyme Caspase-2 may increase long-term cancer risk

Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead increase the risk of chronic liver damage and cancer as we age.

13 Jan 2026

Gene regulators could restore the aging body's ability to self-repair

As we age, we don't recover from injury or illness like we did when we were young. But new research from UCSF has found gene regulators - proteins that turn genes on and off - that could restore the aging body's ability to self-repair.

12 Jan 2026

Weight loss normalizes fat tissue at cellular level

It is well known that obesity typically leads to inflammation and dysfunction of fat tissue that increases the risk of developing metabolic diseases such as diabetes and cardiovascular diseases.

12 Jan 2026

Metabolic BMI reveals hidden health risks in normal weight individuals

People of normal weight may also be at risk of diabetes and similar diseases. A study from the University of Gothenburg reveals that those with an unexpectedly high so-called metabolic BMI have up to a five times higher risk level.

12 Jan 2026

Bowel preparation for colonoscopies may temporarily alter gut balance, preclinical study suggests

New preclinical research suggests that bowel preparation procedures for colonoscopies may temporarily alter gut balance, culminating in unappreciated effects in patients with compromised gastrointestinal health.

8 Jan 2026

Specific gut bacteria found to drive alcohol production in patients with auto-brewery syndrome

Researchers at University of California San Diego, Mass General Brigham, and their colleagues have identified specific gut bacteria and metabolic pathways that drive alcohol production in patients with auto-brewery syndrome (ABS).

8 Jan 2026

Exposure to micro- and nanoplastics linked to rising number of people with chronic IBD

A research team led by the Medical University of Vienna and the University of Vienna has investigated a possible link between the rising number of people with chronic inflammatory bowel disease and the increasing exposure to micro- and nanoplastics (MNPs).

8 Jan 2026

Liver News and Research

UT Southwestern performs first regional whole-liver chemotherapy for rare eye cancer

GOP promotes MAHA agenda in bid to avert midterm losses. Dems point to contradictions.

Blood metabolites reveal who will develop type 2 diabetes years before diagnosis

Researchers discover how Mycoplasma pneumoniae acquires cholesterol from human hosts

Father's early behavior linked to child's heart and metabolic health years later

New insights into long-term liver injury after Kasai portoenterostomy for biliary atresia

Cancer mortality drops 34% as treatments and early detection improve

New oral drug safely lowers triglycerides and other blood lipids in Phase 1 trial

UC San Diego project aims to bioprint patient-specific transplantable human livers

Gut bacteria compound during pregnancy protects offspring from fatty liver disease

CRISPR-Cas3: A safer gene-editing tool shows promise for transthyretin amyloidosis treatment

PFAS exposure linked to gestational diabetes and insulin problems

Preclinical study reveals potential new treatment for severe liver fibrosis

Blocking liver enzyme Caspase-2 may increase long-term cancer risk

Gene regulators could restore the aging body's ability to self-repair

Weight loss normalizes fat tissue at cellular level

Metabolic BMI reveals hidden health risks in normal weight individuals

Bowel preparation for colonoscopies may temporarily alter gut balance, preclinical study suggests

Specific gut bacteria found to drive alcohol production in patients with auto-brewery syndrome

Exposure to micro- and nanoplastics linked to rising number of people with chronic IBD

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News